These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
12. Potential antiedematous effects of intravitreous anti-VEGF, unrelated to VEGF neutralization. Behar-Cohen F; Dernigoghossian M; Andrieu-Soler C; Levy R; Cohen R; Zhao M Drug Discov Today; 2019 Aug; 24(8):1436-1439. PubMed ID: 31173913 [TBL] [Abstract][Full Text] [Related]
13. Letter to the Editor: Ranibizumab 0.3 mg for Persistent Diabetic Macular Edema After Recent, Frequent, and Chronic Bevacizumab: The ROTATE Trial. Călugăru D; Călugăru M Ophthalmic Surg Lasers Imaging Retina; 2018 Mar; 49(3):160. PubMed ID: 29554381 [No Abstract] [Full Text] [Related]
14. Emergency department visits after intravitreal bevacizumab and ranibizumab injections in diabetic patients. Johnson D; Jagan L; Kurji A; Jumaa K; Sharma S Can J Ophthalmol; 2014 Dec; 49(6):e146-8. PubMed ID: 25433751 [No Abstract] [Full Text] [Related]
15. LESS IS MORE: Reducing Injections and Optimizing Vision With Anti-VEGF Therapy for nAMD, DR, and DME. Retina; 2024 May; 44(5S):S1-S16. PubMed ID: 38739858 [No Abstract] [Full Text] [Related]
16. Long-term effect of anti-vascular endothelial growth factor injections on intraocular pressure. Nariani A; Williams B; Hariprasad SM Indian J Ophthalmol; 2016 Sep; 64(9):643-647. PubMed ID: 27853011 [TBL] [Abstract][Full Text] [Related]
17. Resolution of diabetic papillopathy after a single intravitreal injection of ranibizumab. Willerslev A; Munch IC; Larsen M Acta Ophthalmol; 2012 Aug; 90(5):e407-9. PubMed ID: 22268957 [No Abstract] [Full Text] [Related]
18. Angiogenic and inflammatory markers in the intraocular fluid of eyes with diabetic macular edema and influence of therapy with bevacizumab. Funk M; Schmidinger G; Maar N; Bolz M; Benesch T; Zlabinger GJ; Schmidt-Erfurth UM Retina; 2010 Oct; 30(9):1412-9. PubMed ID: 20711086 [TBL] [Abstract][Full Text] [Related]
19. A longitudinal study to assess the frequency and cost of antivascular endothelial therapy, and inequalities in access, in England between 2005 and 2015. Hollingworth W; Jones T; Reeves BC; Peto T BMJ Open; 2017 Oct; 7(10):e018289. PubMed ID: 29061629 [TBL] [Abstract][Full Text] [Related]
20. Monitoring ocular drug therapy by analysis of aqueous samples. Campochiaro PA; Choy DF; Do DV; Hafiz G; Shah SM; Nguyen QD; Rubio R; Arron JR Ophthalmology; 2009 Nov; 116(11):2158-64. PubMed ID: 19700195 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]